       Document 0377
 DOCN  M9460377
 TI    The trading of sex for drugs or money and HIV seropositivity among
       female intravenous drug users.
 DT    9404
 AU    Astemborski J; Vlahov D; Warren D; Solomon L; Nelson KE; Department of
       Epidemiology, Johns Hopkins School of Public; Health, Baltimore, MD.
 SO    Am J Public Health. 1994 Mar;84(3):382-7. Unique Identifier : AIDSLINE
       MED/94175180
 AB    OBJECTIVES. Data from 538 women in a cohort study recruited in 1988-1989
       were analyzed to determined whether trading sex for drugs or money was
       independently associated with human immunodeficiency virus (HIV)
       seroprevalence in a population of female intravenous drug users.
       METHODS. The women were grouped according to the number of partners with
       whom they reported trading sex for drugs or money during the previous 10
       years: none, 1 through 49 (low), or 50 or more (high); the prevalence of
       HIV seropositivity in the three groups was 23.2%, 23.7%, and 47.6%,
       respectively. Logistic regression was used to compare the low- and
       high-trade groups separately with the group that reported no trading.
       RESULTS. Low trading was not associated with seroprevalent HIV
       infection. In a multivariate model, high trading (compared with no
       trading) was significantly associated with HIV seropositivity after
       adjustment for cocaine use, history of sexually transmitted diseases,
       and duration of intravenous drug use. CONCLUSIONS. These data indicate
       that, among intravenous drug-using women, high levels of trading sex for
       drugs or money were independently associated with HIV infection. This
       group needs to be targeted for further intensive intervention.
 DE    Adult  Cohort Studies  Female  Human  HIV Seropositivity/*EPIDEMIOLOGY
       Odds Ratio  Prevalence  *Prostitution  Risk Factors  Sex
       Behavior/STATISTICS & NUMER DATA  Sexual Partners  Substance Abuse,
       Intravenous/*COMPLICATIONS  Support, U.S. Gov't, P.H.S.  JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

